References
Manzi SM, Stark VE, Ramsey-Goldman R: Epidemiology and classification of systemic lupus erythematosus. In Rheumatology edn 3. Edited by Hochberg M, Silman A, Smolen J, et al. Edinburgh. Elsevier; 2003: 1291–1296.
Buyon JP, Petri MA, Kim MY, et al.: The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Int Med 2005, 142:953–962.
Writing Group for the Women’s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002, 288:321–333.
Speroff L: Clinical appraisal of the women’s health initiative. J Obstet Gynaecol Res 2005, 31:80–93.
Rights and permissions
About this article
Cite this article
Domsic, R.T., Manzi, S. Hormone therapy in systemic lupus erythematosus. Curr Rheumatol Rep 7, 455–456 (2005). https://doi.org/10.1007/s11926-005-0051-6
Issue Date:
DOI: https://doi.org/10.1007/s11926-005-0051-6